4 completed, 1 recruiting, 1 withdrawn. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Recruiting 1, Withdrawn 1 |
Follow brexpiprazole: new trials by email Literature Review of brexpiprazole trials Research Report on brexpiprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) Escitalopram, Brexpiprazole - Major Depressive Disorder | Phase 4 | Recruiting | Nova Scotia Health Authority | 400 | 2023-01-20 | 2026-06-11 |
| Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety Brexpiprazole - Major Depressive Disorder (MDD) | Phase 4 | Withdrawn | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-08-29 | 2023-01-30 | |
| Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder Brexpiprazole - Major Depressive Disorder | Phase 4 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 122 | 2021-04-01 | 2024-02-02 |
| Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder Brexpiprazole, Treatment as Usual - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | University of Massachusetts, Worcester | 50 | 2018-06-19 | 2025-05-23 |
| A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) Brexpiprazole, Ketamine, Placebo - Depression | Phase 4 | Completed | Massachusetts General Hospital | 51 | 2017-09-14 | 2020-07-24 |
| Brexpiprazole for Bipolar Depression Brexpiprazole - Bipolar Depression | Phase 4 | Completed | University of Texas Southwestern Medical Center | 21 | 2017-03-01 | 2019-03-13 |
Depression (3) · Depressive Disorder, Major (3) · Alcoholism (1) · Bipolar Disorder (1) · Psychotic Disorders (1) · Schizophrenia (1) · Substance-Related Disorders (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Massachusetts General Hospital (1) · Nova Scotia Health Authority (1) · University of Massachusetts, Worcester (1) · University of Texas Southwestern Medical Center (1)
United States (3) · Canada (2)
Eva Kohegyi, MD (1) · Maurizio Fava, MD (1) · Rudolf Uher, MD, PhD (1) · Sherwood Brown, M.D., Ph.D. (1) · Xiaoduo Fan, MD (1)